JK-2

JK-2

Biochem/physiol Actions

JK-2 is a phosphorothioate-based hydrogen sulfide (H2S) donor that shows greatly accelerated H2S release upon protonation-induced intramolecular cyclization at acidic pH ([H2S]/time/pH = 94 µM/4.5 min/pH 5.0, 84 µM/4.5 min/pH 6.0, 36 µM/90 min/pH 7.4, 21 µM/90 min/pH 8.0 with JK-2; [JK-2] = 100 µM at time 0) and is superior to GYY4137 in H2S generation both in buffer (﹤5 µM H2S/90 min/pH 5.0-8.0 with GYY4137) and in cells without cytotoxicity up to 400 µM in H9c2 and HeLa cultures. JK-2 protects H9c2 rat myoblasts from anoxia/reoxygenation (A/R; 1 hr 2% O2, then 6 hr reoxygenation with 400 µM H2O2) treatment (100% vs. 60% viability with or without 25 µM JK-2) and is efficacious in reducing infarct size per area-at-risk (INF/AAR) upon myocardial ischemia-reperfusion (MI/R) injury induction in mice in vivo (55% and 56% INF/AAR redcution with 50 µg/kg and 100 µg/kg, respectively, via intracardiac injection).

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level Manufacturer Storage Temp. Solubility Form Assay Price Quantity
3575400 JK-2 white to beige 100 SIGMA-ALDRICH 2-8°C H2O: 20 mg/mL, clear powder ≥90% (NMR)
£536.25 (exc VAT) per 25MG
-
+
3575401 JK-2 white to beige 100 SIGMA-ALDRICH 2-8°C H2O: 20 mg/mL, clear powder ≥90% (NMR)
£165.75 (exc VAT) per 5MG
-
+